SCHEMBL2201029

SCHEMBL2201029

CCOC(=O)c1c(C(F)(F)F)nn(-c2cccc(C(F)(F)F)c2)c1C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 3/20 0.53
MAPT P10636 3/20 0.52
APP P05067 1/20 0.52
ADORA1 P30542 1/20 0.52
PDE4B Q07343 1/20 0.52
ALDH1A1 P00352 3/20 0.51
LMNA P02545 2/20 0.48
POLB P06746 2/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
TP53 P04637 1/20 0.48
CYP2C9 P11712 3/20 0.48
KDM4E B2RXH2 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP2C19 P33261 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
NPY5R Q15761 2/20 0.46
ELANE P08246 2/20 0.46
CYP3A4 P08684 1/20 0.46
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2201286 0.90 PDE4D (0.67) PDE4DMAPTAPPADORA1PDE4B
SCHEMBL2197562 0.85 MAPT (0.49) PDE4DMAPTAPPADORA1PDE4B
SCHEMBL2200696 0.84 POLB (0.58) ALDH1A1POLBSMN1; SMN2NPY5RMEN1
SCHEMBL2198107 0.83 MAPT (0.50) PDE4DMAPTAPPADORA1PDE4B
SCHEMBL2200666 0.82 LMNA (0.48) PDE4DMAPTAPPADORA1PDE4B
SCHEMBL2201988 0.78 MAPT (0.50) PDE4DMAPTAPPADORA1PDE4B
SCHEMBL22920709 0.78 MAPT (0.53) MAPTAPPADORA1ALDH1A1LMNA
SCHEMBL8341452 0.78 HTT (0.56) MAPTAPPADORA1ALDH1A1SMN1; SMN2
SCHEMBL2200430 0.78 MAPT (0.49) PDE4DMAPTAPPADORA1PDE4B
SCHEMBL16691194 0.77 DGAT1 (0.55) MAPTAPPADORA1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977358-B2 Pyrazol derivatives HOFFMANN-LA ROCHE INC. (US) 2011-07-12 US disclosed
EP-2182953-A2 NEW PYRAZOL DERIVATIVES F. Hoffmann-Roche AG (CH) 2010-05-12 EP disclosed
US-20090029963-A1 PYRAZOL DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2009-01-29 US disclosed
WO-2009013211-A2 NEW PYRAZOL DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2009-01-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090029963-A1 PYRAZOL DERIVATIVES CCR1, CCR3, CCRL2 PDE4D 814/4885MAPT 4214/4885APP 4793/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.